Skip to content

A CLINICAL STUDY TO COMPARE THE EFFECT OF BAVITHA TRIPHALA (PROCESSED TRIPHALA)AND NAVA GULUGLULU IN DYSLIPIDEMIA (MEDOROGA)

Comparative Clinical Evaluation Of Processed Triphala in the Management of Dyslipidemia - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075651
Enrollment
200
Registered
2024-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I998- Other disorder of circulatory system

Interventions

None listed

Sponsors

MANNAM AYURVEDA CO OPERATIVE MEDICAL COLLEGE MSM PO PANDALAM PIN 689501
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both sexes having any one or all of the following altered lipid levels will be selected. (ATP III Guidelines, NCEP) Total cholesterol above 200mg/ di LDL cholesterol above 130mg/di HDL cholesterol below 40 mg/di Triglycerides above 150mg/di Age group- 30 - 70 years Patients are informed of the given written consent.

Exclusion criteria

Exclusion criteria: Patients in the age group below 30 years and above 70 years. Patients having serious Cardiac disorders like MI and cardiac failure. Pregnant and lactating women. Severe hepatic disorders. The patient has a history of untreated thyroid disorders. Uncontrolled Diabetes mellitus Known case of any type of Malignancy, Renal insufficiency. Patients who are not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
Evaluation of the efficacy of this intervention on serum Lipid levels, Body weight, Body Mass Index (BMI), and Fasting Blood Glucose, will be evaluated before treatment and on the 15th, 30th day and 45th day during the treatment. Changes in subjective criteria like Palpitation, exertional dyspnea, fatigue, corneal arcus, and xanthelasma will also be interrogated and recorded before treatment and after completion of the intervention. Conclusions were drawn. using appropriate statistical techniques. Timepoint: 15th, 30th day and 45thday -DURING THE TREATMENT

Secondary

MeasureTime frame
ASSES THE COMPARATIVE EFFICACY BETWEEN PROCESSED TRIPHALA AND NAVAGULGULU IN DYSLIPIDEMIATimepoint: FOLLOW UP-3 MONTHS

Countries

India

Contacts

Public ContactDR ARYA PRABHU

Shri JJT University

ayudrajith@gmail.com8848384191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026